Search for a Medicine

  • Medicines
 
 

Showing 221-240 of 513 matching medicines

Product listings were last updated on 29/04/2024
Trade Name Licence Number & Holder Documents
Revestive
Powder and solvent for solution for injection

Compare
EU/1/12/787/003
Authorised: 23/06/2017
Takeda Pharmaceuticals International AG Ireland Branch
SPC PIL IPAR
Revinty Ellipta
Inhalation powder, pre-dispensed

Compare
EU/1/14/929/001-003
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
SPC PIL IPAR
Revinty Ellipta
Inhalation powder, pre-dispensed

Compare
EU/1/14/929/004-006
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
SPC PIL IPAR
Revlimid 10 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 10mg Capsules

Compare
EU/1/07/391/002
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 15 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 15mg Capsules

Compare
EU/1/07/391/003
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 2.5 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 2.5mg Capsules

Compare
EU/1/07/391/005
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 20 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 20mg Capsules

Compare
EU/1/07/391/009
Authorised: 19/02/2015
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 25 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 25mg Capsules

Compare
EU/1/07/391/004
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 5 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 5mg Capsules

Compare
EU/1/07/391/001

Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid 7.5 mg hard capsules
Capsule, hard


Generics List: Lenalidomide 7.5mg Capsules

Compare
EU/1/07/391/006
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revolade
Film-coated tablet

Compare
EU/1/10/612/007-009
Authorised: 19/09/2013
Novartis Europharm Limited
SPC PIL IPAR
Revolade
Powder for oral suspension

Compare
EU/1/10/612/013
Authorised: 04/04/2016
Novartis Europharm Limited
SPC PIL IPAR
Revolade
Film-coated tablet

Compare
EU/1/10/612/1-3

Novartis Europharm Limited
SPC PIL IPAR
Revolade
Film-coated tablet

Compare
EU/1/10/612/4-6
Authorised: 11/03/2010
Novartis Europharm Limited
SPC PIL IPAR
Reyataz
Oral powder

Compare
EU/1/03/267/012
Authorised: 21/06/2016
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR
Reyataz
Capsule, hard

Compare
EU/1/03/267/01-7

Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR
Reyataz
Capsule, hard

Compare
EU/1/03/267/8-9
Authorised: 17/04/2008
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR
REZOLSTA
Film-coated tablet

Compare
EU/1/14/967/001
Authorised: 19/11/2014
Janssen-Cilag International NV
SPC PIL IPAR
Rezzayo
Powder for concentrate for solution for infusion

Compare
EU/1/23/1775/001
Authorised: 22/12/2023
Mundipharma GmbH
SPC PIL IPAR
Rhinaspray 21 micrograms per metered dose, Nasal Spray Solution
Nasal spray, solution

Compare
PA23180/021/001
Authorised: 21/03/1997
Opella Healthcare France SAS T/A Sanofi
SPC PIL